Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection
ConclusionAspirin use may have chemo-preventive effect on recurrence of hepatitis B virus-related HCC after curative resection.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
More News: Aspirin | Cancer | Cancer & Oncology | Carcinoma | Cholesterol | Cirrhosis | General Medicine | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Statin Therapy | Study | Urology & Nephrology